Who we are
Who we are
Welcome to Accelera, a premium tier Contract Research Organization (CRO), working and collaborating with pharmaceutical and biotechnology companies around the world.
Accelera is committed to supporting all stages of drug discovery and development by offering tailored services spanning multiple disciplines, including early formulation development, preclinical profiling, drug safety, metabolism, bioanalysis and pharmacokinetics (PK).
At Accelera, a unique platform of integrated scientific, technological and regulatory expertise is available to sponsors and partners, built on decades as part of the international pharmaceutical industry.
By predicting and managing potential toxic, pharmacokinetic and metabolic issues, Accelera can truly add value to your discovery and development programs.
Accelera is a wholly owned business unit of Nerviano Medical Sciences (NMS).
With Accelera, Experience Results.
Welcome to Accelera, a premium tier Contract Research Organization (CRO), working and collaborating with pharmaceutical and biotechnology companies around the world.
Accelera is committed to supporting all stages of drug discovery and development by offering tailored services spanning multiple disciplines, including early formulation development, preclinical profiling, drug safety, metabolism, bioanalysis and pharmacokinetics (PK).
At Accelera, a unique platform of integrated scientific, technological and regulatory expertise is available to sponsors and partners, built on decades as part of the international pharmaceutical industry.
By predicting and managing potential toxic, pharmacokinetic and metabolic issues, Accelera can truly add value to your discovery and development programs.
Accelera is a wholly owned business unit of Nerviano Medical Sciences (NMS).
With Accelera, Experience Results.
© Accelera | Credits | Terms of use